Gliomas in adults: Guidance on investigations, diagnosis, treatment and surveillance

Anna Lerner(Barts Health NHS Trust), Kieran Palmer(Barts Health NHS Trust), Tom Campion(Barts Health NHS Trust), Thomas O Millner(Barts Health NHS Trust), Emily E. Scott(Barts Health NHS Trust), C. Lorimer(University Hospitals Sussex NHS Foundation Trust), Dimitrios Paraskevopoulos(Barts Health NHS Trust), Gráinne McKenna(Barts Health NHS Trust), Silvia Marino(Barts Health NHS Trust), Rachel Lewis(Barts Health NHS Trust), Nick Plowman(Barts Health NHS Trust)
Clinical Medicine
September 1, 2024
Cited by 29Open Access
Full Text

Abstract

Primary brain tumours are rare but carry a significant morbidity and mortality burden. Malignant gliomas are the most common subtype and their incidence is increasing within our ageing population. The diagnosis and treatment of gliomas involves substantial interplay between multiple specialties, including general medical physicians, radiologists, pathologists, surgeons, oncologists and allied health professionals. At any point along this pathway, patients can present to acute medicine with complications of their cancer or anti-cancer therapy. Increasing the awareness of malignant gliomas among general physicians is paramount to delivering prompt radiological and histopathological diagnoses, facilitating access to earlier and individualised treatment options and allows for effective recognition and management of anticipated complications. This article discusses evidence-based real-world practice for malignant gliomas, encompassing patient presentation, diagnostic pathways, treatments and their complications, and prognosis to guide management outside of specialist centres.


Related Papers

No related papers found

Powered by citation graph analysis